Multiple Myleoma

6 clinical trials · Condition

Record	Firm	Date
Teclistamab Plus Autologous Lymphocyte Infusion (ALI) for the Treatment of R/R Multiple Myeloma (NCT06880601)	Gruppo Italiano Malattie EMatologiche dell'Adulto	2025-11-01
Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma (NCT06663046)	Wondercel Biotech (ShenZhen)	2025-07-01
GR1803 Injection in Patients With RRMM (NCT06952075)	Genrix (Shanghai) Biopharmaceutical Co., Ltd.	2025-04-24
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma (NCT05645107)	Grifols Therapeutics LLC	2022-12-26
Study of Lymphoma in Asia (NCT01584141)	National Cancer Institute (NCI)	2011-07-05
Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers (NCT00074490)	National Cancer Institute (NCI)	2004-01-01

Every clearance here is in the API, with alerts when new ones post.